TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer

Transient receptor potential vanilloid type-2 (TRPV2) is an ion channel that is triggered by agonists like cannabidiol (CBD). Triple negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Chemotherapy is still the first line for the treatment of TNBC patients; howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbaz, Mohamad, Ahirwar, Dinesh, Xiaoli, Zhang, Zhou, Xinyu, Lustberg, Maryam, Nasser, Mohd W., Shilo, Konstantin, Ganju, Ramesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173360/
https://www.ncbi.nlm.nih.gov/pubmed/30323891
http://dx.doi.org/10.18632/oncotarget.9663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173360/
https://www.ncbi.nlm.nih.gov/pubmed/30323891
http://dx.doi.org/10.18632/oncotarget.9663

Ejemplares similares